M. Peart
Molecular Biology · 2006
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 30 citations into it; #15,399 of 17,773 by trust here, #9,136 by citations
Whom M. Peart trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Peart overall
Papers from M. Peart's perspective
Ordered by how strongly the researchers M. Peart trusts endorse each paper. Same corpus, a different order for every researcher.
- Clinical development of histone deacetylase inhibitors as anticancer agents. (Annual Review of Pharmacology and Toxicology)
- Deacetylation of p53 modulates its effect on cell growth and apoptosis (Nature)
- Aggresomes, inclusion bodies and protein aggregation. (Trends in Cell Biology)
- Life in the balance: how BH3-only proteins induce apoptosis. (Current Opinion in Cell Biology)
- Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. (Molecules and Cells)
- Acetylation and deacetylation of non-histone proteins. (Gene)
- Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. (Proceedings of the National Academy of Sciences of the United States of America)
- Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. (Proceedings of the National Academy of Sciences of the United States of America)
- HSP90 and the chaperoning of cancer (Nature Reviews. Cancer)
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer (Nature Genetics)
Their papers
- Anticancer activities of histone deacetylase inhibitors (2006) — 2,938 citations